HCFA Proposes Faster And Broader Coverage For Carotid Stent Trials
This article was originally published in The Gray Sheet
Executive Summary
The Health Care Financing Administration's proposed coverage policy change for carotid artery stenting would be the first national coverage policy requiring local carriers to cover all trials of a specific Category B device type.
You may also be interested in...
HCFA Conditional Coverage of PTA Is Stroke of Luck For Carotid Stent Trials
The Health Care Financing Administration's national coverage of percutaneous transluminal angioplasty (PTA) under Medicare could help speed up enrollment in the CREST trial.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”